The relationship between EGFR genomic alteration and SAMD9-positive tumor cells, which are characterized by an immunosuppressive phenotype [21], highlights the need for future work to investigate clarify how EGFR genomic changes sculpt microenvironmental evolution and cellular niche formation in glioblastoma. This evidence concerns the gene EGFR and glioblastoma.